1. Introduction {#s0005}
===============

Low grade gliomas (LGG; World Health Organization grade II) ([@bb0120]) is the most common type of primary brain tumor in young adults ([@bb0105]). A majority of patients with LGG experience tumor-related epilepsy during the course of the disease ([@bb0015]; [@bb0130]). The impact of tumor-related epilepsy on quality of life for patients with LGG is profound due to life-threatening complications associated with epilepsy onset as well as long-term cognitive damage induced by the use of antiepileptic drugs ([@bb0015]; [@bb0090]; [@bb0140]). Previous studies have suggested a number of risk factors for LGG-related epilepsy, including tumor location, peritumoral environment, and altered expression of the genes mediating neurotransmission([@bb0050]; [@bb0100]; [@bb0130]; [@bb0135]; [@bb0140]; [@bb0145]), though the underlying etiology of such epilepsy remains to be elucidated.

Medical imaging, especially MRI, is indispensable in the investigation of the correlation between LGG and its secondary epilepsy for the ability to detect the brain activity noninvasively. Previous MRI-based demographic studies have mainly investigated the association between tumor location and related epilepsy, observing that involvement of eloquent ([@bb0100]), cortical ([@bb0150]), and insular regions ([@bb0080]) is linked with the epilepsy occurrence in LGG patients. Further, a voxel-based imaging analysis provided a probabilistic risk atlas of glioma-related epilepsy ([@bb0135]). However, tumor location may be one among a number of comprehensive risk factors for LGG-related epilepsy, and few researchers have focused on the association between quantitative imaging features of intrinsic tumor lesions and epilepsy occurrence.

Advances in pattern recognition tools have facilitated the development of radiomics, which involves the extraction of a large number of quantitative features from medical images in order to determine relationships among these features and a given underlying pathophysiology. Radiomics analysis of such large imaging data sets has been successfully employed in the field of oncology ([@bb0065]; [@bb0070]), and there is increasing interest within the field in defining association maps between tumor heterogeneity and imaging features ([@bb0045]). By extracting high-throughput quantitative features from routine acquired CT images, radiomics enables the noninvasive profiling of tumor heterogeneity ([@bb0005]). Recent advances in radiomics have enabled oncologists to deliver more personalized medical care with regard to tumor detection, phenotypic subtypes, and assessment of therapeutic responses ([@bb0010]; [@bb0055]; [@bb0060]; [@bb0085]). Given the potential of radiomics analysis for providing a more reliable estimation of risk for LGG-related epilepsy, the development of a multivariable prediction model combining quantitative imaging features is a necessary step in enhancing care and treatment for this patient population.

In the present study, we collected T2-weighted MR Images from 286 patients with LGG and subsequently constructed a radiomics signature by combining multiple imaging biomarkers selected from tumor location features and 3-D imaging features as well as possible interactions among these features. Furthermore, we developed a radiomics nomogram that incorporated both the radiomics signature and clinical characteristics for individual prediction of LGG-related epilepsy risk.

2. Methods {#s0010}
==========

2.1. Patients {#s0015}
-------------

A total of 286 patients with LGGs who had been surgically treated at Beijing Tiantan Hospital between September 2008 and March 2015 were consecutively enrolled in this retrospective study. *There was a partial overlap (\<50%) between the datasets in our previous study (*[@bb0135]*) and that in the present study.* All included cases met the following criteria: histopathologically confirmed grade II gliomas according to World Health Organization criteria 2016 (patients without diagnostic molecular testing was designated as not otherwise specified categories) ([@bb0125]), presurgical T2-weighted MRIs of the brain, and no prior craniotomy or stereotactic biopsy. All enrolled patients were listed in chronological order, the first 194 patients were identified as primary cohort and other 92 patients were identified as validation cohort. The clinical characteristics of the patients, including age, gender, tumor location, and history of epilepsy occurrence are summarized in [Table 1](#t0005){ref-type="table"}. Our study was approved by the ethics committee of Beijing Tiantan Hospital. The flow chart of the study is illustrated in [Fig. 1](#f0005){ref-type="fig"}.Table 1Clinical characteristic of patients in the primary and validation cohorts.Table 1CharacteristicsPrimary cohort*P*Validation cohort*P*EpilepsyNo epilepsyEpilepsyNo epilepsyAge, y, median (range)37(15--64)40(17--67)0.19742(17--66)45(8--72)0.249Sex, M/F81/5529/290.21941/1916/160.085MRI characteristicsTumor size, mean ± SD73.5 ± 51.272.6 ± 58.30.867[a](#tf0005){ref-type="table-fn"}71.4 ± 54.573.2 ± 60.10.796[a](#tf0005){ref-type="table-fn"}  Tumor pathology (%)Oligodendroglioma14100.178710.166IDH-mutant and 1p/19q-codeleted10541NOS4530Diffuse Astrocytoma43190.87618140.187IDH-mutant261098IDH-wildtype7333NOS10663Oligoastrocytoma79290.29935170.631NOS79293517Radiomics score0.8236 ± 0.291730.3540 ± 0.29742\<0.001[a](#tf0005){ref-type="table-fn"}0.6715 ± 0.379910.3734 ± 0.28888\<0.001[a](#tf0005){ref-type="table-fn"}[^2][^3]Fig. 1Flowchart of the study. With manually segmented tumor, we first extracted 474 quantitative imaging features, including location features, 3-D imaging features, and their interactions from masked presurgical T2-weighted MRIs. The general view of the feature extraction algorithm was shown in the figure. Then, feature selection was applied on the extracted features with E-net and a radiomics signature was constructed with the selected features. Finally, radiomics signature and clinical characteristics were incorporated into a nomogram for individually prediction.Fig. 1

2.2. Evaluation of tumor-related epilepsy {#s0020}
-----------------------------------------

Patients were considered to have experienced tumor-related epilepsy when a history of at least one seizure with the presence of an enduring alteration (i.e., LGG) in the brain ([@bb0025]) was reported. History of epilepsy and seizure types (generalized and focal) were evaluated by an epileptologist based on the presentation of the epilepsy according to the classification and terminology of the International League Against Epilepsy (ILAE) ([@bb0030]).

2.3. Brain imaging and tumor masking {#s0025}
------------------------------------

MRI scans were obtained on a Magnetom Trio 3.0T scanner (Siemens, Erlangen, Germany) using a 12-channel receive-only head coil. The T2-weighted image parameters were as follows: repetition time = 5800 ms; echo time = 110 ms; flip angle = 150 degrees; 24 slices; field of view = 240 × 188 mm^2^; voxel size = 0.6× 0.6 × 5.0 mm^3^; matrix = 384 × 300. Tumors were traced directly on the brain MRIs using MRIcron (<http://www.mccauslandcenter.sc.edu/mricro/mricron>). Masks of the brain tumors were drawn on each patient\'s T2-weighted images in native space by two board-certified neuroradiologists, which were blinded to the patients\' clinical information. Areas that produced abnormally hyperintense signals on T2-weighted images were identified as LGG tumor areas. The tumor masks were combined when there was less than a 5% discrepancy between the individual masks identified by the two neuroradiologists. When a \>5% discrepancy existed between these two masks, the masks utilized were determined by a senior neuroradiologist.

2.4. Extraction of quantitative imaging features {#s0030}
------------------------------------------------

We first generated a "tumor cube" covering the area of the tumor using the tumor mask and T2-weighted images for each patient. Then, three groups of quantitative features were extracted depending on the tumor cube.

*Group I*: Location features. For the extraction of tumor location features, a coordinate system with anterior commissure (AC) as the origin point was constructed in Montreal Neurological Institute (MNI) space. The data of each patient was registered to the MNI template, and the polar coordinates of the centroid of the tumor and the distance from AC to the centroid of the tumor were calculated. Seven location features were extracted, including the polar coordinates (*r*, *θ*, and *Φ*) of the centroid of the tumor and Cityblock distance, Chebyshev distance, Mahalanobis distance, and Cosine distance from the AC to the centroid of the tumor (See [Fig. 2](#f0010){ref-type="fig"}).Fig. 2Tumor masking and quantitative location information. Masks of the brain tumors were drawn on each patient\'s T2-weighted images in native space by two board-certified neuroradiologists. We set up a coordinate system with the anterior commissure (AC) as the origin point. Polar coordinates (r, θ, and Φ) of the centroid of the tumor were identified as location features.Fig. 2

*Group II: Three dimensional imaging features. A total of 349 3-D imaging features of the tumor, including 13 first order statistical features (Energy, Entropy, Kurtosis, Mean, Maximum, Minimum, Median, Range, RMS, Skewness, Variance, Standard deviation, and Uniformity), seven shape- and size-based features (Compactness I, Compactness II, sphericity, spherical disproportion, Surface to volume ratio (SVR), Volume, Surface area), 25 texture features (GLCM: Energy, Entropy, Correlation, Contrast, Homogeneity, Variance, Sum average, Autocorrelation, Cluster shade, Cluster tendency, Probability, and Inverse variance, and GLRL: Short Run Emphasis (SRE), Long Run Emphasis (LRE), Gray Level Non-Uniformity (GLN), Run Length Non-Uniformity (RLN), Run Percentage (RP), Low Gray Level Run Emphasis (LGLRE), High Gray Level Run Emphasis (HGLRE), Short Run Low Gray Level Emphasis (SRLGLE), Short Run High Gray Level Emphasis (SRHGLE), Long Run High Gray Level Emphasis (LRHGLE), Long Run Low Gray Level Emphasis (LRLGLE), Fractal Dimension (FD), Average Fractal Dimension (FDa)), and 304 wavelet features recalculated of the first order statistics features and textural features on images after 3D "Coiflet 1" wavelet transform.*

*Group III*: Interaction features between location features and 3-D imaging features without wavelet. The products of each location feature and each 3-D imaging feature without wavelet were detected as interaction features. 119 statistically significant (*p* *\<* *0.05*) epilepsy-related interactions calculated using linear regression were used as potential predictors in the development of the multivariable model.

The detailed information and formula to detect the 475 MR-based imaging features was described in the supplement (See [Table 3](#t0015){ref-type="table"}).Table 2Performance of the different features.Table 2MetricsAUCAccuracyPrimary cohortValidation cohortPrimary cohortValidation cohortLocation (95%)0.7567 (0.7146 to 0.7962)0.6541 (0.6237 to 0.7065)70.10% (64.95% to 74.74%)66.30% (61.96% to 69.56%)3-D Imaging features (95%)0.7857 (0.7563 to 0.8364)0.7612 (0.7072 to 0.7921)75.26% (72.16% to 77.32%)70.65% (66.30% to 73.91%)Radiomics signature (95%)0.8754 (0.8265 to 0.9213)0.8162 (0.7318 to 0.9005)79.38% (76.22% to 82.22%)75.00% (71.74% to 78.26%)[^4]Table 3Quantitative image features extracted for prediction.Table 3ClassFeaturesNumbersLocationFirst order statisticsPolar coordinate (r, *θ*, *Φ*), cityblock, chebychev, mahalanobis, and cosine distance7Shape based featuresEnergy, Entropy, Kurtosis, Mean, Maximum, Minimum, Median, Range, RMS, Skewness, Variance, Standard deviation, Uniformity13Textural featuresCompactness I, Compactness II, sphericity, spherical disproportion, Surface to volume ratio (SVR), Volume, Surface area7Wavelet featuresGray level co-occurrence matrix (GLCM)\'s:\
Energy, Entropy, Correlation, Contrast, Homogeneity, Variance, Sum average, Autocorrelation, Cluster shade, Cluster tendency, Probability, Inverse variance;\
Gray level run-length matrix (GLRL)\'s:\
Short Run Emphasis (SRE), Long Run Emphasis (LRE), Gray Level Non-Uniformity (GLN), Run Length Non-Uniformity (RLN), Run Percentage (RP), Low Gray Level Run Emphasis (LGLRE), High Gray Level Run Emphasis (HGLRE), Short Run Low Gray Level Emphasis (SRLGLE), Short Run High Gray Level Emphasis (SRHGLE), Long Run High Gray Level Emphasis (LRHGLE), Long Run Low Gray Level Emphasis (LRLGLE);\
Fractal Dimension (FD), Average Fractal Dimension (FDa)253D "Coiflet 1" wavelet transform on images with 8 decompositions: LLL, LLH, LHL, LHH, HLL, HLH, HHL, HHH; Then re-calculate the first order statistics features and textural features.304Interaction featuresStatistically significant (*p* \< 0.05) seizure related interactions between location features and 3-D imaging features without wavelet119Total475

2.5. Feature selection and prediction {#s0035}
-------------------------------------

To reduce any type of over-fitting or bias in the multivariate analysis, the Elastic net (*E*-Net) was used in order to select the most predictive features from the primary data set. E-net aimed at selecting the model that achieved the best trade-off between goodness of fit and model complexity by minimizing the residual sum of squares of estimating errors plus the penalty term, which made it suitable for a regression model. It can be seen that the E-net penalty was a weighted sum of the least absolute shrinkage and selection operator (LASSO) penalty and ridge penalty. In the present study, models including a small number of features were regarded to be of lower complexity. Glmnet ([@bb0035]) (<http://statweb.stanford.edu/~tibs/lasso.html>), which could provide efficient procedures for fitting the entire LASSO or *E*-net regularization path for linear regression, was used in order to obtain the key features.

*The epileptic status of the patients (1 for epileptic and 0 for non-epileptic) was estimated with the imaging features using the following model:*$$y = \mathit{sigmoid}\left( {\ \sum\limits_{i = 1}^{n}\beta_{i}x_{i} + \beta_{0} + \varepsilon} \right)$$*where y was the epileptic status of the patients; n was the number of features, here n = 475; x*~*i*~ *(i = 1, 2, ..., n) was the independent parameter; β*~*i*~ *(i = 0, 1, 2, ..., n) was the coefficient, and ε was the error term. By forcing many parameters to zero, feature selection can be performed. The aim was to minimize the following cost function:*$$\sum\limits_{i = 1}^{N}\left( {y_{i} - \mathit{sigmoid}\left( {\sum\limits_{j = 1}^{n}\beta_{j}x_{\mathit{ij}} - \beta_{0}} \right)} \right)^{2} + \lambda\sum\limits_{j = 1}^{n}\left( {\alpha\left| \beta_{j} \right| + 0.5\left( {1 - \alpha} \right)\left( \beta_{j} \right)^{2}} \right)$$*where y*~*i*~ *was the epileptic status of the ith patients; N was the number of patients; x*~*ij*~ *was the jth feature of the ith patients; and λ and α were tuning parameters.* We selected λ and α in the E-net model used 10-fold cross-validation via minimum criteria. Specifically, the values for the parameter α were restricted between 0 and 1 in steps of 0.1, and the values of λ were restricted between 0.001 and 1. Features with non-zero coefficients resulted by the optimal λ and α were selected as potential predictors for further analysis. A radiomics signature was calculated for each patient via a linear combination of selected features that were weighted by their respective coefficients. Based on the constructed radiomics signature, the AUC, and classification accuracy were calculated as metrics used to assess the quantitative discrimination performance of the model in the primary cohort and validation cohort.

2.6. Development of an individualized prediction model {#s0040}
------------------------------------------------------

Multivariable logistic regression analysis was conducted with the following clinical information: age, sex, histopathology and radiomics signature. A model for epilepsy detection was developed on the basis of the primary cohort. Backward step-wise selection was applied by using the likelihood ratio test with Akaike\'s information criterion as the stopping rule ([@bb0020]; [@bb0115]).

Based on the multivariable logistic analysis in the primary cohort, a radiomics nomogram for LGG-related epilepsy detection was built to provide a quantitative tool for clinical use. Calibration curves were plotted to assess the calibration of the radiomics nomogram, accompanied with the Hosmer-Lemeshow test. (A significant test statistic implies that the model does not calibrate perfectly.) *The calibration curves described the agreement between the estimated risk of epilepsy and the actual rate of epilepsy. The calibration curve can be drawn by plotting* $\hat{P}$ *on the x-axis while P*~*c*~ = \[1 + *exp* − (*γ*~0~ + *γ*~1~*L*)\]^−1^ *on the y-axis. Here, P*~*c*~ *represented the actual probability of epilepsy, and*$\ L = \mathit{logit}\left( \hat{P} \right)$*,* $\hat{P}$ *was the estimated risk of epilepsy, γ*~0~ *was corrected intercept, and γ*~1~ *was slope estimate.* And Harrell\'s C-index was measured to quantify the discrimination performance of the radiomics nomogram. The nomogram was subjected to bootstrapping validation (1000 bootstrap resamples) to detect a relatively corrected performance.

3. Results {#s0045}
==========

3.1. Demographic and clinical data {#s0050}
----------------------------------

There were no significant differences between the two cohorts in epilepsy prevalence (*p* = 0.406). Patients with epilepsy accounted for 70.1% and 65.2% in the primary and validation cohort. There were also no significant differences in the clinical characteristics between the epilepsy group and non-epilepsy group, either within the primary and validation cohorts, which justified their use as training and testing cohorts.

3.2. Feature selection and Radiomics signature building {#s0055}
-------------------------------------------------------

*E*-net was performed to detect key features for prediction ([Fig. 3](#f0015){ref-type="fig"}C). *epileptic (λ) was selected in the E-net with 10-fold cross-validation* via *minimum criteria in the primary cohort. The misclassification error was plotted* versus log *(λ). A λ value of 0.055 was chosen (minimum criteria) according to 10-fold cross-validation. The α value of 0.8 was chosen with minimum criteria in the loop from 0 to 1 in steps of 0.1.* Eleven features with non-zero coefficients were consequently selected from all 475 features, including Uniformity, GLCM_Cluster_Tendency, GLRL_SRE, LLL_GLCM_Probability, HLL_Minimum, HLH_STD, HHH_Minimum, Φ\*GLRL_LRLGE, cityblock\*FD, cosine\*GLCM_Correlation, and cosine\*GLCM_Probability. Radiomics signature was obtained with a linear combination of these features achieved using E-net. The predictive ability of the radiomics signature was interpreted according to the ROC curve ([Fig. 3](#f0015){ref-type="fig"}D). It achieved a performance with classification accuracy = 79.38%, AUC = 0.8754 in the primary cohort and classification accuracy = 75.00%, AUC = 0.8162 in the validation cohort (See [Table 2](#t0010){ref-type="table"}).Fig. 3ROC curve of multivariate analysis with location features (A) and 3-D imaging features (B) (the pink lines represent the performance in the primary cohort and the blue lines represent the performance in the validation cohort). (C) Tuning parameter (λ) selection in the E-net used 10-fold cross-validation via minimum criteria. (D) ROC curve of radiomics signature (the pink lines represent the performance in the primary cohort and the blue lines represent the performance in the validation cohort).Fig. 3

3.3. Performance of Radiomics nomogram {#s0060}
--------------------------------------

Nomogram for epilepsy detection was developed combining clinical characteristics and radiomics signature ([Fig. 5](#f0025){ref-type="fig"}). The calibration curve of the nomogram for the probability of epilepsy demonstrated a well agreement in the primary cohort ([Fig. 6](#f0030){ref-type="fig"}). The Hosmer-Lemeshow test yielded nonsignificant statistics (*p* = 0.229), which suggested that there was no departure from the perfect fit. The C-index of the nomogram was 0.8769 (95% CI: 0.8303--0.9235) within the primary cohort and 0.8152 (95% CI: 0.7311--0.8993) within the validation cohort.

4. Discussion {#s0065}
=============

In the present study, we aimed to elucidate a radiomics signature combining MRI features associated with LGG-related epilepsy. Our findings demonstrated that MR-based radiomics features may reflect epilepsy susceptibility in LGG patients. The radiomics signature successfully stratified patients according to their epilepsy risk. Incorporating the radiomics signature and clinical characteristics into a nomogram further facilitated the prediction of epilepsy risk.

Recent developments in the field of radiomics have allowed for the extraction of high-throughput imaging features, enabling oncologists to derive more precise information with regard to individual patient conditions and treatment options ([@bb0075]). A number of studies have developed radiomics-based predictive models for various clinical characteristics, including survival outcomes ([@bb0005]), lymph node metastasis ([@bb0055]), and treatment responses ([@bb0095]). Moreover, some researchers have suggested that radiomics analysis may be able to predict the clinical characteristics and molecular background of brain tumors by combining various quantitative MRI features ([@bb0040]; [@bb0060]). As tumor-related epilepsy was among the most important clinical characteristics associated with LGGs, we constructed a radiomics signature that combined three-dimensional imaging features, tumor locations, and their interactions with *E*-net. The radiomics signature achieved a relatively high discrimination accuracy and AUC in both primary and validation cohorts, suggesting that the radiomics analysis of the present study was effective in detecting LGG-related epilepsy. Additionally, the established nomogram benefits for the clinical application of rapid epilepsy prediction. Our model incorporated radiomics signature and clinical characteristics, the risk LGG-related epilepsy could be individually and accurately evaluated.

For the realization of radiomics analysis, effective imaging features are necessary for further prediction. Several 3-D imaging features were selected as key features in the present study, which have been applied in previous radiomics studies ([@bb0005]; [@bb0060]). These features not only described the intuitive sense of tumors but also provided abundant information on tumor heterogeneity and microenvironments ([@bb0045]). *In the present study, the most predictive features of epilepsy status were selected based on the E-net model, and the biological correlations between these features and epilepsy occurrence could also be revealed preliminarily. For instance, the results of the present study indicated that Uniformity, a radiological indicator for the consistency of the images, which reflected tumor homogeneity (*[@bb0005]*), could serve as a predictive factor of the epilepsy status. As known to us, higher tumor homogeneity was usually associated with lower tumor malignancy, and lower tumor malignancy may be accompanied with increased epilepsy risk based on clinical findings. Thus, we can speculate that, higher Uniformity indicated higher epilepsy risk, which was consistent with the result of the present study* ([Fig. 4](#f0020){ref-type="fig"}).Fig. 4T2-weighted images with tumor masks for two cases with LGG. Top row: images in a patient who was classified into the epilepsy group with an epilepsy risk score of 1.1066. Bottom row: images in a patient who was classified into the non- epilepsy group with a radiomics score of −0.0970. (Patients with radiomics score \>0 would be classified into epilepsy group, while patients with radiomics score \<0 would be classified into non-epilepsy group).Fig. 4Fig. 5Developed radiomics nomogram. The radiomics nomogram was developed in the primary cohort, with the radiomics signature and clinical characteristics (including sex, age, and histopathology) incorporated. With the nomogram, probability of epilepsy for each patient could be calculated on the basis of logistic regression formula using the total points.Fig. 5Fig. 6Calibration curve of the radiomics nomogram in the primary cohort.Fig. 6

Tumor location is another influential factor associated with epilepsy. A probabilistic risk atlas of LGG-related epilepsy has been illustrated ([@bb0135]). However, previous studies ([@bb0080]; [@bb0100]; [@bb0150]) were mainly based on segmented and masked tumor lesions. While the imaging information inside the tumor area was ignored, and the location information was used as categorized data. Considering that differences in epilepsy susceptibility may exist for different sub-regions of a brain lobe, quantitative descriptions of tumor location are necessary. We accordingly constructed a coordinate system in which the tumor location was accurately described using the polar coordinates of the centroid of the tumor as well as the distances. This quantitative description provided more detailed tumor location information and allowed us to incorporate tumor location into the estimation model of epilepsy risk.

In addition, the interactions between tumor location and other risk factors were considered in the present prediction model, as tumors of the same size in various locations (or tumors in the same location of various sizes) may be associated with different degrees of epilepsy risk. Therefore, we investigated the interactive effects between 3-D imaging features and tumor location. Reasonably, the interactions between tumor location and 3-D imaging features were significantly associated with epilepsy (*p* *\<* *0.05*) in the multivariate classification model. Our results demonstrate that the interactions provided significant contributions to the epilepsy prediction model, and that inconsistent increases in epilepsy risk were accompanied by the growth of gliomas in various locations. The observed susceptibility to tumor-related epilepsy was also in accordance with the probabilistic risk of epilepsy determined using voxel-based mapping ([@bb0135]). Our findings indicate that interaction features may provide additional important information for the prediction of LGG-related epilepsy.

Radiomics integrates comprehensive imaging features, though it is important to note that inclusion of unrelated features may result in over-fitting or bias in the predictive model. To exclude redundant features and promote the creation of an effective prediction model, we preserved 11 key features that preferentially contributed to epilepsy prediction and achieved a relatively good prediction performance. We utilized E-net, which is suitable for the regression of high-dimensional data and computationally more efficient and less prone to overfitting ([@bb0110]), as the feature selection method in the current study. The results demonstrated that selected key feature achieved the classification performance.

*The prediction results of the present study, when taken with those of previous studies, also suggested that the combination of imaging features with location information may allow for a construction of an improved prediction model. While location was only one of the risk factors for LGG related epilepsy, the other 468 features used in the present study may provide additional information of epilepsy risk and help the prediction of epilepsy occurrence.*

The present study also possesses some limitations. First, stereotactic electroencephalographic data was not available for localization of epilepsy originations. In this study, the diagnosis of epilepsy was based on clinical presentation. As patients with LGG are often referred for surgery shortly following diagnosis, many are unfortunately unable to undergo electroencephalography prior to surgery. Second, the divergence of tumor histopathology with epilepsy remains controversial and was consequently not considered in this study. Despite the above limitations, this study quantitatively detected radiomics features and the machine learning classification was well validated. *A deep learning model was encouraged to be applied in future studies with multicenter collection and a larger sample of data.*

5. Conclusions {#s0070}
==============

In conclusion, we identified an effective radiomics signature combining a series of imaging features, which allowed for the effective non-invasive prediction of LGG-related epilepsy. Furthermore, our results suggest that radiomics analysis may be an effective method for the individualized evaluation and management of LGG-related epilepsy.

Conflict of interest {#s0075}
====================

The authors declare that they have no conflict of interest. The authors alone are responsible for the content and writing of the paper.

Appendix A. Supplementary data {#s0080}
==============================

Supplementary materialImage 1

This paper is supported by National Natural Science Foundation of China under Grant No. 81772012, 81501549, 81470083, the National Key Research and Development Plan of China under Grant No. 2016YFC0902500, and 2017YFA0205200, the National Basic Research Program of China (973 Program) under Grant No. 2015CB755500.

Supplementary data to this article can be found online at <https://doi.org/10.1016/j.nicl.2018.04.024>.

[^1]: These authors contributed equally to the work of this manuscript.

[^2]: NOS, not otherwise specified.

[^3]: Result of *t*-test.

[^4]: Abbreviations: AUC, area under ROC curve.
